Skip to main content
Christopher Barbieri, MD, Urology, New York, NY

ChristopherEBarbieriMDPhD

Urology • New York, NY

Surgical Oncology

Peter M. Sacerdote Distinguished Associate Professor in Urologic Oncology Weill Cornell Medicine

Request Appointment

Overview of Dr. Barbieri

Dr. Christopher Barbieri is an urologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, New York-Presbyterian Hospital, and NewYork-Presbyterian/Columbia University Irving Medical Center. He received his medical degree from Vanderbilt University School of Medicine and has been in practice 10 years. He is one of 193 doctors at New York-Presbyterian Hospital and one of 65 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Urology. He has more than 100 publications and over 500 citings.

Education & Training

  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Urology, 2009 - 2013
  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Surgery, 2007 - 2009
  • Vanderbilt University School of Medicine
    Vanderbilt University School of MedicineClass of 2007

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2009 - 2026
  • Urology
    American Board of Urology Urology

Awards, Honors, & Recognition

  • MetLife Clinical Investigator Award Damon Runyon Cancer Research Foundation, 2016
  • Rising Star in Urology Research Urology Care Foundation / AUA, 2015
  • Challenge Award Prostate Cancer Foundation, 2014
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Impact of Pelvic Radiation Therapy on Inflatable Penile Prosthesis Reoperation Rates  
    Christopher E Barbieri, James A Kashanian, The Journal of Sexual Medicine
  • Introduction to “Molecular Drivers of Prostate Cancer Development, Progression, and Resistance to Therapy”  
    Christopher Barbieri, MD, Urologic Oncology
  • Molecular Subtypes of Prostate Cancer  
    Christopher Barbieri, MD, Current Oncology Reports

Authored Content

  • SPOP Mutated/ CHD1 Deleted Lethal Prostate Cancer and Abiraterone SensitivityMarch 2018

Press Mentions

  • Putting the Brakes on Prostate Cancer Cells
    Putting the Brakes on Prostate Cancer CellsDecember 13th, 2024
  • What You Need to Know About Prostate Cancer Treatments
    What You Need to Know About Prostate Cancer TreatmentsOctober 7th, 2024
  • Prostate Cancer’s Spread Modeled with CRISPR Barcoding Technology
    Prostate Cancer’s Spread Modeled with CRISPR Barcoding TechnologySeptember 23rd, 2024
  • Join now to see all

Professional Memberships

Dr. Christopher Barbieri, Dr. Christopher Barbieri, MD, Dr. C Barbieri, Dr. Christopher E Barbieri